Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cryopreserved Amniotic Membrane
- Development stage
- Unknown
- Lead developer
- Med Institute
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical, Surgical Implantation
01
Overview
Cryopreserved Amniotic Membrane (CAM) is a biological tissue graft derived from the innermost layer of the human placenta, the amnion. It is processed and cryopreserved to maintain the structural and biochemical properties of the native tissue, including a complex extracellular matrix and a variety of bioactive signaling molecules. CAM provides a structural scaffold for cell migration and proliferation while delivering growth factors (such as TGF-beta, EGF, and FGF) and anti-inflammatory cytokines that promote regenerative healing and reduce scar formation. It is primarily used in the treatment of chronic, non-healing wounds and in orthopedic applications to support the repair of soft tissues like tendons and ligaments. MED Institute Inc. is currently conducting a post-market registry to evaluate the clinical outcomes and utilization of CAM in these settings.
- Other names
- Cryopreserved human amniotic membraneAmniotic membrane graftAmniotic membrane
02
Targets
TGFB (GARP–latent transforming growth factor beta 1 complex)FGF (Fibroblast growth factor 6)
Beyond the preview
Go deeper on Cryopreserved Amniotic Membrane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cryopreserved Amniotic Membrane.